A change in federal law to keep consumers from being left in the dark about prescription drug pricing is on President Donald Trump’ desk. And, he’s expected to sign it.
It is rare for Republicans and Democrats to agree in Washington; rarer still for something to pass the Senate unanimously and the House on a voice vote. But this legislation did.
It stops insurance industry middlemen known as prescription benefits managers from writing gag orders into contracts with retailers--gag orders forbidding pharmacists from telling customers about low cost medication options.